- Home
- COEP vs LOAN Comparison
COEP vs LOAN Comparison
Compare COEP & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | LOAN |
|---|---|---|
| Founded | 2017 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 51.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | COEP | LOAN |
|---|---|---|
| Price | $15.85 | $4.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 71.0K | 40.1K |
| Earning Date | 11-14-2025 | 10-24-2025 |
| Dividend Yield | N/A | ★ 9.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.46 |
| Revenue | $500,996.00 | ★ $7,138,128.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.47 |
| P/E Ratio | ★ N/A | $10.09 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.31 | $4.29 |
| 52 Week High | $21.41 | $6.05 |
Technical Indicators
Market Signals| Indicator | COEP | LOAN |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 44.58 |
| Support Level | $15.40 | $4.64 |
| Resistance Level | $16.80 | $4.83 |
| Average True Range (ATR) | 1.57 | 0.14 |
| MACD | -0.11 | 0.04 |
| Stochastic Oscillator | 20.64 | 74.77 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.